Revolutionizing Multiple Myeloma Treatment: Targeted Precision with CS1-Specific CAR Polypeptides
TS-065435 — The Need: The treatment landscape for multiple myeloma (MM) demands novel, targeted solutions to improve patient outcomes. Existing therapies often fall short in addressing the complex challenges posed by MM, necessitating a more precise and effective approach.
The Technology: Our technology introd…
- College: College of Medicine (COM)
- Inventors: Yu, Jianhua; Chu, Jianhong; Hofmeister, Craig
- Licensing Officer: Bhatti, Hamid
